Related Experiment Videos
Immunogenic and Genetic Factors in Rheumatic Fever
Carreño-Manjarrez1, Visvanathan, Zabriskie
1Laboratory of Clinical Microbiology and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA. zabrisk@rockvax.rockefeller.edu
Current Infectious Disease Reports
|November 30, 2000
Summary
Rheumatic fever, a leading cause of childhood heart disease in developing nations, is linked to an abnormal immune response to streptococcal bacteria. This response involves both antibody (humoral) and cell-mediated immunity, potentially exacerbated by genetic factors.
Area of Science:
- Immunology
- Cardiology
- Pediatrics
Background:
- Rheumatic fever is a significant cause of acquired heart disease in children globally, particularly in developing countries.
- Its pathogenesis is hypothesized to involve an aberrant host immune response to streptococcal antigens.
- This response may include cross-reactivity between bacterial antigens and host tissues.
Purpose of the Study:
- To review recent evidence supporting the immune-mediated hypothesis of rheumatic fever pathogenesis.
- To highlight the role of cellular immunity in causing cardiac damage.
- To explore the potential influence of genetic predisposition.
Main Methods:
- Review of recent scientific literature and evidence.
- Analysis of immunological mechanisms involved in rheumatic fever.
- Examination of genetic factors contributing to disease susceptibility.
Main Results:
- Evidence supports a significant role for both humoral and cellular immune responses in rheumatic fever.
- The cellular immune response appears crucial in mediating cardiac tissue damage.
- Genetic predisposition may influence an individual's susceptibility to developing rheumatic fever.
Conclusions:
- The immune response to streptococcal antigens, particularly the cellular arm, is central to rheumatic fever pathogenesis and cardiac sequelae.
- Genetic factors likely play a role in disease susceptibility.
- Further research into these mechanisms is warranted for targeted interventions.